The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...

Data from two late-stage studies show that LLY's once-weekly insulin injections achieved results that are similar to daily ...

Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...

New data show Lilly’s longer-lasting insulin matched daily shots in controlling blood sugar, adding to positive findings the company disclosed in May.

Insulin can be a critical part of managing diabetes, but patients may not know all the ins and outs of using the medication effectively. Luckily, the American Diabetes Association (ADA) has plenty ...

29 lb more than participants on insulin degludec 27 lb more than participants on insulin glargine Mounjaro stimulates insulin production, helping to improve insulin resistance. It acts on GLP-1 ...

The U.S. Food and Drug Administration on Monday approved the expanded use of an automated insulin pump system to include those with type 2 diabetes. It's the first such system for use by people ...

Ovalle and team compared originator insulin glargine (Lantus) to Gan & Lee insulin glargine (GL Glargine). Lantus was developed by Acentis Pharmaceuticals and received FDA approval in 2000. In 2014, ...